KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Clinical trials for KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN explained in plain language.

Never miss a new study

Get alerted when new KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN trials appear

Sign up with your email to follow new studies for KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Scientists test re-engineered immune cells to fight multiple cancers

Disease control Terminated

This early-stage study tested a new type of personalized cancer treatment. Researchers collected a patient's own immune cells (T cells), modified them in a lab to better recognize and attack cancer cells, and then infused them back into the patient. The goal was to see if this ap…

Matched conditions: KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Get alerted when new KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN trials appear

Scientists test re-engineered immune cells to fight multiple cancers